Adheris Health Limited reports FY26 half-year results
Key points
- Profit after tax up 423.9% to $7.3M
- Revenue from continuing operations down 49.0% to $23.3M
- Gain on disposal of Australian and New Zealand business unit
Full summary
Adheris Health Limited (formerly MedAdvisor Limited) has reported a 423.9% increase in profit after tax to $7,349,795 for the half-year ended 31 December 2025, compared to $1,402,915 in the prior corresponding period. This result includes a $17,479,199 gain on the disposal of the company's Australian and New Zealand business unit to Jonas Software on 4 July 2025. Revenue from continuing operations declined 49.0% to $23,346,274, down from $45,741,019 in the prior corresponding period. The company noted that the principal continuing activities of the Group consisted of pharmacy-driven, innovative patient engagement solutions that simplify the patient medication journey to empower better health. At 31 December 2025, the Group had $8,085,032 in cash and cash equivalents and net assets of $8,941,604. There were no dividends paid, recommended or declared during the current or previous financial half-year.
Summary generated by a large language model. Please interpret with care.